Dear IMS members and Colleagues,
Welcome to the new edition of our newsletter!
We are looking forward to welcoming you all to Los Angeles this week for the 19th International Myeloma Society Annual Meeting.
This is the first meeting since our decision to make the IMS meeting annual. This was in response to the incredible progress in research in myeloma, both clinical and translational. In response to comments from our last meeting, we have developed a new format that is focused on the future of myeloma and centered on six key themes:
- Disease Monitoring
- High Risk Multiple Myeloma
- Induction for Newly Diagnosed Myeloma
- Relapsed Multiple Myeloma
- Immune Constitution and Vaccination
- Cellular Therapies
Each session will include:
- Four top abstracts pertaining to the theme of the session
- A talk summarizing the findings and putting them in context with the current state
- Challenges and future directions
- Roundtable discussion with senior faculty and audience interaction
Our meeting will also include Meet the Expert Sessions, Career Development Workshops, keynote speakers, joint symposia, our award ceremony and more. Whether you are joining online or in person, we look forward to welcoming you!
The IMS is now involved in funding research and providing direction to the great progress being made in myeloma. We are also very active in advocacy work. At our meeting, you will hear further details we have planned a “FDA-IMS Workshop: Future of Drug Development in Multiple Myeloma” in November. To help provide access and guidance worldwide, we are also pursuing the Therapeutic MAP (TMap) project and other significant educational efforts.
There is still time to register. If you cannot attend in person, we hope you will participate in our meeting virtually. In order to accommodate our colleagues around the world, we are offering simultaneous interpretation in both Mandarin and Spanish. Please be sure to share this information with your colleagues.
There is more in store for IMS, so please continue to check our website regularly for more updates. If you have any questions about our activities, membership, or any ideas for our newsletter, please reach out to Moira Hancock.
We will meet you all to Los Angeles either in person or virtually and look forward to your participation to enhance our efforts.
Nikhil Munshi, MD
President
